Provided by Tiger Trade Technology Pte. Ltd.

Nuveen California Select Tax-Free Income Portfolio

13.29
0.0000
Volume:- -
Turnover:- -
Market Cap:85.77M
PE:-33.94
High:13.29
Open:13.29
Low:13.29
Close:13.29
52wk High:13.45
52wk Low:12.41
Shares:6.45M
Float Shares:6.45M
Volume Ratio:- -
T/O Rate:- -
Dividend:0.54
Dividend Rate:4.04%
EPS(TTM):-0.3916
EPS(LYR):0.3507
ROE:-2.94%
ROA:2.42%
PB:1.02
PE(LYR):37.90

Loading ...

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

GlobeNewswire
·
Jan 28

Nuveen California Select Tax-Free Income Portfolio Merges Into Nuveen Select Tax-Free Income Portfolio

Reuters
·
Jan 12

BRIEF-Nuveen Closed-End Funds Announce Update To Reorganization Distributions

Reuters
·
Dec 31, 2025

Nuveen California Select Tax-Free Income Portfolio to Merge Into Nuveen Select Tax-Free Income Portfolio

Reuters
·
Dec 31, 2025

Nuveen Select Tax-Free Income Portfolio to Merge California and New York Funds

Reuters
·
Dec 19, 2025

Nuveen Select Tax-Free Income Portfolios Announce Shareholder Approval of Reorganization

THOMSON REUTERS
·
Dec 19, 2025

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

GlobeNewswire
·
Dec 08, 2025

Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch

GlobeNewswire
·
Nov 12, 2025

Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

GlobeNewswire
·
Nov 03, 2025

Nuveen California Select Tax-Free Income Portfolio Files Initial Statement of Beneficial Ownership; Robert Tanner Page Listed as VP and Treasurer

Reuters
·
Oct 30, 2025

Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis

TIPRANKS
·
Oct 28, 2025

Nuveen California Select Tax-Free Income Portfolio Releases Latest Distribution Report

Reuters
·
Sep 03, 2025

Nuveen California Select Tax-Free Income Portfolio Releases Distribution Report

Reuters
·
Aug 02, 2025